Table 1. Patient characteristics.
| Patient | Diagnosis | Age | Sex | Background | Immunosuppressive treatment | Lesion |
|---|---|---|---|---|---|---|
| 1 | PTLD | 43 | M | KT | CsA, MMF | Brain |
| 2 | PTLD | 42 | F | KT | TAC, PSL | Pleura |
| 3 | OIIA-LPD | 81 | F | RA | MTX | AG |
| 4 | OIIA-LPD | 70 | F | RA | MTX | LN |
| 5 | OIIA-LPD | 60 | F | RA | MTX | Tonsil |
| 6 | OIIA-LPD | 78 | F | RA | MTX | LN |
| 7 | OIIA-LPD | 67 | F | RA | MTX | Gum |
| 8 | OIIA-LPD | 81 | F | RA | MTX | Pharynx |
| 9 | OIIA-LPD | 84 | F | RA | MTX, SASP | Lung |
| 10 | OIIA-LPD | 82 | F | RA | PSL, SASP, BUC, MTX, TAC | Lung |
| 11 | OIIA-LPD | 56 | M | RA | BUC, SASP, PSL | LN |
| 12 | OIIA-LPD | 69 | M | RA | PEN, PSL | LN |
| 13 | OIIA-LPD | 79 | F | MCTD | PSL, TAC | LN |
PTLD, post-transplant lymphoproliferative disorder; OIIA-LPD, other iatrogenic immunodeficiency-associated lymphoproliferative disorder; KT, kidney transplantation; RA, rheumatoid arthritis; MCTD, mixed connective tissue disease CsA, cyclosporin A; MMF, mycophenolate mofetil; TAC, tacrolimus; PSL, prednisolone; MTX, methotrexate; SASP, salazosulfapyridine; BUC, bucillamine; PEN, d-penicillamine; AG, adrenal gland; LN, lymphoid node